• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM SARS-COV-2 TOTAL (COV2T); SARS-COV-2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problems False Negative Result (1225); No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/05/2020
Event Type  malfunction  
Manufacturer Narrative
The calibration was acceptable and the quality control (qc) was within range.The customer stated that they batch their covid sample test and the atellica im is cleaned before and after the runs, per instructions for use (ifu).The customer stated that a few other covid samples were run along with this patient sample and no other patient sample results are being questioned.Siemens healthcare diagnostics is investigating.The ifu states in the limitations section: "patient specimens may be nonreactive if collected during the early (pre-seroconversion) phase of illness or due to a decline in titer over time.In addition, the immune response may be depressed in elderly, immunocompromised, or immunosuppressed patients." a false negative/non-reactive result would be correlated with clinical history and presentation and may lead to additional testing and/or continued precautions to avoid infection with negligible clinical impact.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).Mdr 1219913-2020-00147 was filed for the same patient sample on a different test date.
 
Event Description
The customer obtained a discordant nonreactive (negative) atellica im sars-cov-2 total (cov2t) result for a patient sample on (b)(6) 2020.The sample was repeated on the atellica im sars-cov-2 total (cov2t) assay on (b)(6) 2020 and the result was again nonreactive.The patient sample was initially tested on (b)(6) 2020 using the pcr method at (b)(6) and the result was positive.The patient sample was retested at (b)(6) using the pcr method on (b)(6) 2020 and a negative result was obtained.The initial atellica im result was reported to the physician and was not questioned.There are no known reports of patient intervention or adverse health consequences due to the nonreactive cov2t results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2020-00148 on (b)(6) 2020.(b)(6) 2020 correction: in the initial mdr report section d2, the incorrect product code was documented.The correct product code is qko.Section d2 has been updated with this information.In the initial mdr report section h4, the device manufacture date was inadvertently omitted.The device manufacture date is (b)(6) 2020.Section h4 has been updated with this information.(b)(6) 2020, additional information: siemens has investigated this incident.The patient sample is no longer available for further testing and investigation and patient symptomology is not available, therefore, siemens is unable to determine the root cause.The atellica im cov2t ifu (11206906_en rev.(b)(6) 2020) states positive agreement is 100% with a 95% confidence interval of 91.59-100.0%.Siemens is unable to rule out a sample specific issue.Based on the information provided, no product problem is identified.The instrument is performing within specifications.No further evaluation of the device is required.Section h6, the device, method, results and conclusion codes were updated to reflect the additional information.Mdr 1219913-2020-00147 supplemental report 1 was filed for the same patient sample on a different test date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM SARS-COV-2 TOTAL (COV2T)
Type of Device
SARS-COV-2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown, ny
MDR Report Key10185226
MDR Text Key196650034
Report Number1219913-2020-00148
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EUA201367
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 07/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/28/2021
Device Model NumberN/A
Device Catalogue Number11206711
Device Lot Number001
Was Device Available for Evaluation? No
Date Manufacturer Received07/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-